# United States Natural Gas Fund, LP: financial statements, quarterly

UNG · NYSE · CIK 1376227 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ung.md) · [Financials](/companies/ung/financials.md) · [Filings](/companies/ung/filings.md) · [Insiders](/companies/ung/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ung/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [(79.0)](/filings/0001410578-25-000230.md) | [(251)](/filings/0001410578-25-000230.md) | [(162)](/filings/0001104659-26-021507.md) | [177](/filings/0001104659-26-021507.md) | [4.4](/filings/0001104659-26-021507.md) | [56.2](/filings/0001104659-26-021507.md) | [211](/filings/0001104659-26-021507.md) | [(121)](/filings/0001104659-26-021507.md) | [(54.5)](/filings/0001104659-26-021507.md) | [5.4](/filings/0001104659-26-021507.md) | not reported | not reported |
| Net income | $m | [(81.6)](/filings/0001410578-25-000230.md) | [(254)](/filings/0001410578-25-000230.md) | [(165)](/filings/0001104659-26-021507.md) | [174](/filings/0001104659-26-021507.md) | [1.9](/filings/0001104659-26-021507.md) | [53.7](/filings/0001104659-26-021507.md) | [209](/filings/0001104659-26-057766.md) | [(122)](/filings/0001104659-26-092626.md) | [(55.9)](/filings/0001104659-26-021507.md) | [3.7](/filings/0001104659-26-021507.md) | [110](/filings/0001104659-26-057766.md) | [15.4](/filings/0001104659-26-092626.md) |

- Revenue: us-gaap:Revenues
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [816](/filings/0001410578-24-001821.md) | [678](/filings/0001104659-26-021507.md) | [545](/filings/0001410578-25-001154.md) | [540](/filings/0001410578-25-001642.md) | [692](/filings/0001104659-25-108416.md) | [594](/filings/0001104659-26-021507.md) | [295](/filings/0001104659-26-057766.md) | [284](/filings/0001104659-26-092626.md) | [483](/filings/0001104659-25-108416.md) | [438](/filings/0001104659-26-092626.md) | [346](/filings/0001104659-26-057766.md) | [288](/filings/0001104659-26-092626.md) |
| Total assets | $m | [1,158](/filings/0001410578-23-002201.md) | [988](/filings/0001410578-25-000230.md) | [841](/filings/0001410578-24-000685.md) | [715](/filings/0001410578-24-001240.md) | [933](/filings/0001410578-24-001821.md) | [790](/filings/0001104659-26-021507.md) | [446](/filings/0001410578-25-001154.md) | [376](/filings/0001410578-25-001642.md) | [651](/filings/0001104659-25-108416.md) | [579](/filings/0001104659-26-092626.md) | [454](/filings/0001104659-26-057766.md) | [422](/filings/0001104659-26-092626.md) |
| Total liabilities | $m | [1.4](/filings/0001410578-23-002201.md) | [13.9](/filings/0001410578-25-000230.md) | [10.0](/filings/0001410578-24-000685.md) | [3.4](/filings/0001410578-24-001240.md) | [42.8](/filings/0001410578-24-001821.md) | [46.2](/filings/0001104659-26-021507.md) | [25.4](/filings/0001410578-25-001154.md) | [15.1](/filings/0001410578-25-001642.md) | [26.2](/filings/0001104659-25-108416.md) | [28.8](/filings/0001104659-26-092626.md) | [9.9](/filings/0001104659-26-057766.md) | [4.0](/filings/0001104659-26-092626.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [19.9 d](/filings/0001410578-24-001821.md) | [(319) d](/filings/0001104659-26-021507.md) | [(89.5)](/filings/0001410578-25-001154.md) | [231 d](/filings/0001410578-25-001642.md) | [(180) d](/filings/0001104659-25-108416.md) | [86.3 d](/filings/0001104659-26-021507.md) | [268](/filings/0001104659-26-057766.md) | [(87.2) d](/filings/0001104659-26-092626.md) | [(87.9) d](/filings/0001104659-25-108416.md) | [34.3 d](/filings/0001104659-26-021507.md) | [102](/filings/0001104659-26-057766.md) | [(9.4) d](/filings/0001104659-26-092626.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

Shares outstanding: 47,546,103 at 2026-08-04, from the cover of the [10-Q filed 2026-08-07](/filings/0001104659-26-092626.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.